Debt-to-equity in % of Galera Therapeutics, Inc. from Q2 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Galera Therapeutics, Inc. quarterly Debt-to-equity history and change rate from Q2 2020 to Q3 2025.
  • Galera Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -103 %, a 9.05% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Galera Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -103 +10.2 +9.05% 30 Sep 2025
Q2 2025 -104 +14.9 +12.6% 30 Jun 2025
Q1 2025 -106 +19.8 +15.7% 31 Mar 2025
Q4 2024 -109 +27.6 +20.2% 31 Dec 2024
Q3 2024 -113 +29.3 +20.6% 30 Sep 2024
Q2 2024 -119 +29.5 +19.9% 30 Jun 2024
Q1 2024 -126 +29.6 +19% 31 Mar 2024
Q4 2023 -137 +26.4 +16.2% 31 Dec 2023
Q3 2023 -142 +43.8 +23.5% 30 Sep 2023
Q2 2023 -148 +74.9 +33.6% 30 Jun 2023
Q1 2023 -156 +131 +45.8% 31 Mar 2023
Q4 2022 -163 +205 +55.7% 31 Dec 2022
Q3 2022 -186 +418 +69.2% 30 Sep 2022
Q2 2022 -223 +6.85K +96.8% 30 Jun 2022
Q1 2022 -287 -794 -157% 31 Mar 2022
Q4 2021 -368 -612 -251% 31 Dec 2021
Q3 2021 -604 -753 -506% 30 Sep 2021
Q2 2021 -7.07K -8.48K -601% 30 Jun 2021
Q1 2021 507 31 Mar 2021
Q4 2020 244 31 Dec 2020
Q3 2020 149 30 Sep 2020
Q2 2020 1.41K 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.